Calithera Biosciences Inc (CALA)
0.02
-0.01
(-31.03%)
USD |
OTCM |
Apr 24, 16:00
Calithera Biosciences Cash from Operations (Quarterly): -8.598M for Dec. 31, 2022
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | -8.598M |
| September 30, 2022 | -7.736M |
| June 30, 2022 | -11.26M |
| March 31, 2022 | -16.01M |
| December 31, 2021 | -25.57M |
| September 30, 2021 | -7.605M |
| June 30, 2021 | -11.12M |
| March 31, 2021 | -22.00M |
| December 31, 2020 | -23.00M |
| September 30, 2020 | -16.30M |
| June 30, 2020 | -18.00M |
| March 31, 2020 | -27.02M |
| December 31, 2019 | -18.40M |
| September 30, 2019 | -19.68M |
| June 30, 2019 | -20.05M |
| March 31, 2019 | -20.62M |
| December 31, 2018 | -13.89M |
| September 30, 2018 | -16.56M |
| Date | Value |
|---|---|
| June 30, 2018 | -19.44M |
| March 31, 2018 | -14.95M |
| December 31, 2017 | -11.36M |
| September 30, 2017 | -11.30M |
| June 30, 2017 | 1.168M |
| March 31, 2017 | 35.25M |
| December 31, 2016 | -8.773M |
| September 30, 2016 | -7.004M |
| June 30, 2016 | -7.642M |
| March 31, 2016 | -7.606M |
| December 31, 2015 | -9.914M |
| September 30, 2015 | -6.392M |
| June 30, 2015 | -5.998M |
| March 31, 2015 | -7.629M |
| December 31, 2014 | -4.471M |
| September 30, 2014 | -5.657M |
| June 30, 2014 | -4.581M |
| March 31, 2014 | -4.522M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-27.02M
Minimum
Mar 2020
-7.605M
Maximum
Sep 2021
-16.82M
Average
-18.00M
Median
Jun 2020
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.314M |
| Palatin Technologies Inc | -10.48M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.541M |
| Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.023M |
| Cash from Financing (Quarterly) | 0.004M |